Grace Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $8 | $0 |
Gross Profit | -2 | -2 | -2 | -2 |
EBITDA | -938 | -3,088 | -380 | -3,702 |
EBIT | -3,362 | -3,090 | -382 | -3,704 |
Net Income | -938 | -3,362 | 636 | -4,155 |
Net Change In Cash | 0 | 0 | 8 | 0 |
Free Cash Flow | -3,154 | -1,801 | -2,954 | -4,115 |
Cash | 16,862 | 20,005 | 22,133 | 11,055 |
Basic Shares | 15,924 | 15,924 | 13,718 | 11,506 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -11 | -124 | 0 |
EBITDA | -16,672 | -14,619 | -18,123 | -15,340 |
EBIT | -16,679 | -14,630 | -18,247 | -15,589 |
Net Income | -9,568 | -12,853 | -42,429 | -9,819 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,904 | -12,355 | -15,930 | -17,234 |
Cash | 22,133 | 23,005 | 27,875 | 30,339 |
Basic Shares | 12,087 | 7,436 | 7,435 | 6,140 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.08 |
2025-06-30 | -$0.28 |
2025-03-31 | $0.13 |
2024-12-31 | -$0.51 |
